Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:27 pm Unchanged | 2025-09-30 | 13G | Verona Pharma plc VRNA | Pentwater Capital Management LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-11-14 4:26 pm Purchase | 2025-09-30 | 13G | AMC Entertainment Holdings, Inc. AMC | Pentwater Capital Management LP | 48,626,044 9.500% | 48,626,044![]() (New Position) | Filing History |
| 2025-11-14 4:25 pm Purchase | 2025-09-30 | 13G | Core Scientific, Inc. CORZ | Pentwater Capital Management LP | 26,050,000 8.500% | 26,050,000![]() (New Position) | Filing History |
| 2025-11-14 4:24 pm Unchanged | 2025-09-30 | 13G | 89bio, Inc. ETNB | Pentwater Capital Management LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-11-14 4:23 pm Purchase | 2025-09-30 | 13G | CyberArk Software Ltd. CYBR | Pentwater Capital Management LP | 3,665,000 7.300% | 3,665,000![]() (New Position) | Filing History |
| 2025-11-14 4:22 pm Purchase | 2025-09-30 | 13G | Surgery Partners, Inc. SGRY | Pentwater Capital Management LP | 11,681,000 9.100% | 4,681,000![]() (+66.87%) | Filing History |
| 2025-11-14 4:21 pm Sale | 2025-09-30 | 13G | Amedisys, Inc. AMED | Pentwater Capital Management LP | 0 0.000% | -1,715,084![]() (Position Closed) | Filing History |
| 2025-11-14 4:20 pm Sale | 2025-09-30 | 13G | Skechers U.S.A., Inc. SKX | Pentwater Capital Management LP | 0 0.000% | -7,000,000![]() (Position Closed) | Filing History |
| 2025-08-14 4:10 pm Purchase | 2025-06-30 | 13G | Avis Budget Group, Inc. CAR | Pentwater Capital Management LP | 2,950,000 8.400% | 560,000![]() (+23.43%) | Filing History |
| 2025-08-14 4:10 pm Purchase | 2025-06-30 | 13G | Blueprint Medicines Corporation BPMC | Pentwater Capital Management LP | 3,900,000 6.000% | 3,900,000![]() (New Position) | Filing History |
| 2025-08-14 4:09 pm Sale | 2025-06-30 | 13G | United States Steel Corporation X | Pentwater Capital Management LP | 0 0.000% | -20,000,000![]() (Position Closed) | Filing History |
| 2025-08-14 4:08 pm Purchase | 2025-06-30 | 13G | Verve Therapeutics, Inc. VERV | Pentwater Capital Management LP | 6,720,000 7.500% | 6,720,000![]() (New Position) | Filing History |
| 2025-08-14 4:07 pm Purchase | 2025-06-30 | 13G | Amedisys, Inc. AMED | Pentwater Capital Management LP | 1,715,084 5.200% | 1,715,084![]() (New Position) | Filing History |
| 2025-08-14 4:07 pm Purchase | 2025-06-30 | 13G | Surgery Partners, Inc. SGRY | Pentwater Capital Management LP | 7,000,000 5.500% | 7,000,000![]() (New Position) | Filing History |
| 2025-08-14 4:06 pm Purchase | 2025-06-30 | 13G | Skechers U.S.A., Inc. SKX | Pentwater Capital Management LP | 7,000,000 5.400% | 7,000,000![]() (New Position) | Filing History |
| 2025-05-15 4:31 pm Sale | 2025-03-31 | 13G | Smartsheet Inc. SMAR | Pentwater Capital Management LP | 0 0.000% | -8,950,000![]() (Position Closed) | Filing History |
| 2025-05-15 4:31 pm Purchase | 2025-03-31 | 13G | Avis Budget Group, Inc. CAR | Pentwater Capital Management LP | 2,390,000 6.800% | 2,390,000![]() (New Position) | Filing History |
| 2025-02-14 4:09 pm Purchase | 2024-12-31 | 13G | Smartsheet Inc. SMAR | Pentwater Capital Management LP | 8,950,000 6.400% | 8,950,000![]() (New Position) | Filing History |
| 2025-02-14 4:05 pm Sale | 2024-12-31 | 13G | VIZIO Holding Corp. VZIO | Pentwater Capital Management LP | 0 0.000% | -6,750,000![]() (Position Closed) | Filing History |
| 2025-01-13 4:05 pm Sale | 2025-01-08 | 13D | Poseida Therapeutics, Inc. PSTX | Pentwater Capital Management LP | 0 0.000% | -8,625,000![]() (Position Closed) | Filing History |

